Use of OB-104 to treat ocular inflammation

dc.creator	Chiou, George C. Y.
dc.date.accessioned	2019-06-17T16:54:23Z
dc.date.available	2019-06-17T16:54:23Z
dc.date.issued	1993-03-30
dc.identifier.uri	https://hdl.handle.net/1969.1/176479
dc.description.abstract	A novel compound for the treatment and prevention of ocular inflammation is disclosed. The compound, OB-104, is effective at both the early and late phases of inflammation.	en
dc.language	eng
dc.publisher	United States. Patent and Trademark Office
dc.rights	Public Domain (No copyright - United States)	en
dc.rights.uri	http://rightsstatements.org/vocab/NoC-US/1.0/
dc.title	Use of OB-104 to treat ocular inflammation	en
dc.type	Utility patent	en
dc.format.digitalOrigin	reformatted digital	en
dc.description.country	US
dc.contributor.assignee	Texas A&M University System
dc.identifier.patentapplicationnumber	07/801890
dc.subject.uspcprimary	514/369
dc.subject.uspcother	424/427
dc.subject.uspcother	514/912
dc.date.filed	1991-12-03
dc.publisher.digital	Texas A&M University. Libraries
dc.subject.cpcprimary	A61K 31/425
dc.subject.cpcprimary	Y10S 514/912